foxo4-dri senolytic 2023 The disordered p53 transactivation domain is the target of FOXO4 and the compound Frontiers | Senolytic Peptide FOXO4-DRI
Frontiers Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC FOXO4 DRI 2460055 10 9 AdooQ
Pay in 4 interest-free payments of $7.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




